Thu 2/27/2020 09:26 ET
DJIA26957.59124.000.46%TELCO185.600.690.37%GOLD1654.8511.750.71%Shanghai2991.333.290.11%
S&P 5003116.4211.840.38%BANKS454.385.271.16%OIL46.412.325.00%BITCOIN8836.7511.490.13%
NASDAQ8980.7815.270.17%PHARM592.340.530.09%US/EU1.100.000.01%Futures3055.6254.701.79%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - YM BioSciences - YMI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  
From: crainiac (Rep: 4161)Date: 12/09/2012 19:59
Forum: YM BioSciences - Msg #3441Thread #673482866 (Rec: 0)
YM BioSciences Reports Phase I/II Data for JAK Inhibitor CYT387 in Myelofibrosis at ASH 2012

http://www.marketwatch.com/story/ym-biosciences-reports-phase-iii-data-for-jak-inhibitor-cyt387-in-myelofibrosis-at-ash-2012-2012-12-09-17183150

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreYMI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.